ADC Therapeutics is a biotechnology company. Co. is focused on the development of antibody drug conjugates, including research, development, human clinical trials, regulatory approval and commercialization. Antibody drug conjugates (ADCs) are drug constructs which combine monoclonal antibodies specific to particular types of cells with cytotoxic molecules or warheads which seek to kill cancer cells to which the ADC attaches. Co.'s hematology franchise comprises three clinical-stage product candidates, Lonca, Cami and ADCT-602. Co.'s solid tumor franchise comprises two clinical-stage product candidates, Cami and ADCT-601, and two preclinical product candidates, ADCT-901 and ADCT-701. We show 1 historical shares outstanding datapoints in our ADCT shares outstanding history coverage, used to compute ADCT market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing ADCT market cap history over the course of time is important for investors
interested in comparing ADCT's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of ADCT versus a peer is one thing; comparing
ADCT market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like ADCT can fluctuate over the course of history.
With this page we aim to empower investors researching ADCT by allowing them to research the ADCT market cap history. |
Free ADCT Email Alerts:
Video: The Importance of Market Cap
